NCT Number: NCT02525809
Incidence of Dual Mobility Polyethylene Wear in Total Hip Prosthesis. Randomised Study Versus Fixed Insert by Radiostereometric Analysis.
The total hip replacement, with over 120,000 cases per year in France, provides short term, excellent functional results and a significant improvement in quality of life, in almost all cases. However, observation showed that the dislocation is not a rare complication (2-4%) and the lifetime of the implants is limited due to aseptic loosening.
The evaluation process used in this study will be the extent of penetration of the metal femoral head in the cup and micro mobility metal back by radiostereometric analysis (RSA) whose precision provides early results (2 3 years), long before wear and migration are measurable by conventional radiological means. The main objective will be to compare, 2 years after the intervention, the penetration of the metal femoral head in 3 types of inserts: two dual mobility inserts, one at tripod attachment (Novae E®), the other press fit pure (Sunfit®), and a fixed insert (Quartz®).
This is a randomized controlled trial. 105 patients will be enrolled (35 in each group). Patients will be included in each of the two participating centers (Amiens, Caen). The analysis will be made in RSA D7 + 2, 6 months 1, 12 months 1 24 months 1. An assessment will be made to 3 years if the analysis requires it to 2 years.
Analysis of pictures will be centralized in Caen and performed with specific software after transferring images via a secure network.
Looking for future studies?
Notify MeKey information
Conditions
Age range
60 year–75 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- patients older men or women 60-75 years
- with a primary or secondary osteoarthritis or osteonecrosis
- having a functional disorder requiring the installation of a total hip prosthesis of primary
Exclusion criteria
- patients aged 76 years or more
- protected adults
- resumption of PTH
- cephalic prosthesis recovery or intermediate
- resumption of cupules
- primary or secondary malignant tumor of the hip
Treatment and study plan
Sunfit®
DeviceQuartz®
DevicePrimary outcomes
-
Measuring the penetration of the femoral head in the polyethylene inserts by radiostereometric analysis (RSA)
Time frame: change over baseline and 3 years
Sponsors and collaborators
Lead sponsor
University Hospital, Caen
Other
Registry information
Acronym: DOUMOB
Important dates
- Study start
- 2010
- Primary completion
- 2012
- Study completion
- 2015
- First posted
- Aug 17, 2015
- Registry last updated
- Sep 1, 2020
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Morphine COnsumption in Joint Replacement Patients, With and Without GaBapentin Treatment, a RandomIzed ControlLEd Study
NCT00889148
Neurologic Manifestations, Pain
Hamilton, Ontario, Canada
View Trial DetailsEvaluation of X-ray, Acetabular Guides and CT in THR
NCT03072706
Total Hip Replacement
Coventry, West Midlands, United Kingdom
View Trial DetailsPatient Scores and Functional Tests After Hip Surgery
NCT07048041
Patient-reported Outcomes, Total Hip Replacement
Ordu, Turkey (Türkiye)
View Trial DetailsEvaluation of Conventional Antibiotic Prophylaxis During a Change of Hip or Knee Infected at a Time
NCT02272205
Total Hip Replacement
View Trial Details